Although the Ebola virus outbreak ended in 2016, it resurfaced and another outbreak was declared on May 8, 2018 in the Democratic Republic of the Congo (DRC). Specifically, the virus has reached Mbandaka, a major city in the DRC. This is a huge concern to health officials because the virus can spread quickly.
Fortunately, since the end of the previous outbreak of the Ebola virus in 2016, a vaccine to fight the virus was developed and 9,000 doses were recently delivered to the DRC. In trials, this new vaccine has shown a 100% success rate in preventing people from being infected by the Ebola virus.
Fortunately, since the end of the previous outbreak of the Ebola virus in 2016, a vaccine to fight the virus was developed and 9,000 doses were recently delivered to the DRC. In trials, this new vaccine has shown a 100% success rate in preventing people from being infected by the Ebola virus.
Vaccines, including the one fighting the Ebola virus, assist our immune systems fight viruses. Specifically, vaccines help the body develop active immunity, which is long lasting immunity that is developed through immune system cells. To acquire active immunity, special immune cells known as B-cells and T-cells learn to recognize different pathogens, which are harmful organisms or viruses, and then these cells spring into action! B-cells release antibodies, which are proteins that stick to free-floating pathogens such as viruses and bacteria, which makes them easier to catch. T-cells, on the other hand, kill diseased cells to protect other cells from infection.
Once the immune system fights off the original encounter, the memory B-cells and T-cells remember the pathogen. If the pathogen is ever encountered again, then the immune system will activate quickly and remove the threat.
To help our immune system gain acquired immunity, vaccines release a small amount of pathogen into the body and the B-cells and T-cells are able to attack and remember, allowing for immunity.
Based on this information, if someone does not receive the new Ebola vaccine, then he or she has a chance of contracting the virus. Once the virus enters the body, the virus works by targeting dendritic cells, which signal killer T-cells to attack pathogens. Without the dendritic cells, the immune system cannot recognize pathogens and the virus can replicate quickly. Once the virus moves on, it causes damage to blood vessels. Without functioning blood vessels, an infected person will see a drop in blood pressure and multiple organ failure if the virus is left untreated.
If, however, a person receives the Ebola vaccine prior to being infected by the Ebola virus, when the Ebola virus enters the person's body, his or her immune system is ready for the attack. Specifically, the memory B-cells and T-cells will be activated and attack the Ebola virus, which will cause the virus to be eliminated. The hope is that the new Ebola vaccine will help save many lives. Although our immune systems may get by with a little help from vaccines, they really are our microscopic protectors that work tirelessly to help keep our bodies going throughout the day!
No comments:
Post a Comment